292 related articles for article (PubMed ID: 25165123)
21. Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China.
Zhu B; Shi F; Zhang A; Sun X; Xu Z; Xu L; Gao Y; Lv J; Shao Z
Vaccine; 2018 Apr; 36(15):1983-1989. PubMed ID: 29523451
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).
Abad R; García-Amil C; Navarro C; Martín E; Martín-Díaz A; Vázquez JA
J Infect; 2021 Apr; 82(4):37-44. PubMed ID: 33610688
[TBL] [Abstract][Full Text] [Related]
23. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
Tzanakaki G; Xirogianni A; Tsitsika A; Clark SA; Kesanopoulos K; Bratcher HB; Papandreou A; Rodrigues CMC; Maiden MCJ; Borrow R; Tsolia M
Vaccine; 2021 Mar; 39(11):1621-1630. PubMed ID: 33597116
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and genotypic characterization of meningococcal isolates in Tunis, Tunisia: High diversity and impact on vaccination strategies.
Brik A; Terrade A; Hong E; Deghmane A; Taha MK; Bouafsoun A; Khmiri M; Boussetta K; Boukhir S; Jaballah NB; Kechrid A; Smaoui H
Int J Infect Dis; 2020 Feb; 91():73-78. PubMed ID: 31756567
[TBL] [Abstract][Full Text] [Related]
25. Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.
Tzanakaki G; Hong E; Kesanopoulos K; Xirogianni A; Bambini S; Orlandi L; Comanducci M; Muzzi A; Taha MK
BMC Microbiol; 2014 Apr; 14():111. PubMed ID: 24779381
[TBL] [Abstract][Full Text] [Related]
26. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
mBio; 2021 May; 12(3):. PubMed ID: 34006659
[TBL] [Abstract][Full Text] [Related]
27. Molecular typing of group B Neisseria meningitidis'subcapsular antigens directly on biological samples demonstrates epidemiological congruence between culture-positive and -negative cases: A surveillance study of invasive disease over a 13-year period.
Lodi L; Moriondo M; Nieddu F; Ricci S; Guiducci S; Lippi F; Canessa C; Calistri E; Citera F; Giovannini M; Indolfi G; Resti M; Azzari C
J Infect; 2021 Apr; 82(4):28-36. PubMed ID: 33610687
[TBL] [Abstract][Full Text] [Related]
28. Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines.
Muzzi A; Bodini M; Topaz N; Masignani V; Vadivelu K; Marjuki H; Wang X; Serino L; Medini D
mSphere; 2022 Oct; 7(5):e0038522. PubMed ID: 36129279
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
Fazio C; Biolchi A; Neri A; Tomei S; Vacca P; Ambrosio L; Palmieri A; Mori E; La Gaetana R; Pizza M; Giuliani MM; Serino L; Stefanelli P
Hum Vaccin Immunother; 2021 Jul; 17(7):2225-2231. PubMed ID: 33522380
[TBL] [Abstract][Full Text] [Related]
30. High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.
Tozer SJ; Smith HV; Whiley DM; Borrow R; Boccadifuoco G; Medini D; Serruto D; Giuliani MM; Stella M; De Paola R; Muzzi A; Pizza M; Sloots TP; Nissen MD
Hum Vaccin Immunother; 2021 Sep; 17(9):3230-3238. PubMed ID: 33847225
[TBL] [Abstract][Full Text] [Related]
31. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.
Muzzi A; Lu M-C; Mori E; Biolchi A; Fu T; Serino L
mSphere; 2024 Jun; 9(6):e0022024. PubMed ID: 38752729
[No Abstract] [Full Text] [Related]
32. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
[TBL] [Abstract][Full Text] [Related]
33. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
Rossi R; Beernink PT; Giuntini S; Granoff DM
Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
[TBL] [Abstract][Full Text] [Related]
35. Increase in ST-11 serogroup W
Tsang RS; Hoang L; Tyrrell GJ; Minion J; Van Caeseele P; Kus JV; Lefebvre B; Haldane D; Garceau R; German G; Zahariadis G; Hanley B
Can Commun Dis Rep; 2019 Jun; 45(6):164-169. PubMed ID: 31285709
[TBL] [Abstract][Full Text] [Related]
36. Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB).
Efron A; Biolchi A; Sorhouet Pereira C; Tomei S; Campos J; De Belder D; Moscoloni MA; Santos M; Vidal G; Nocita F; Vizzotti C; Pizza M
Hum Vaccin Immunother; 2023 Dec; 19(3):2288389. PubMed ID: 38111094
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis.
Oldfield NJ; Matar S; Bidmos FA; Alamro M; Neal KR; Turner DP; Bayliss CD; Ala'aldeen DA
PLoS One; 2013; 8(7):e69746. PubMed ID: 23936091
[TBL] [Abstract][Full Text] [Related]
38. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
[TBL] [Abstract][Full Text] [Related]
39. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
40. Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.
Perrett KP; McVernon J; Richmond PC; Marshall H; Nissen M; August A; Percell S; Toneatto D; Nolan T
Vaccine; 2015 Sep; 33(39):5217-24. PubMed ID: 26232542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
